Close

Analyst Ratings for Talis Biomedical Corp. (TLIS) [Sells]

TLIS Rating Summary

TLIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TLIS
Overall Rating: SELL   Rating Trend: =   Avg. $ Target: $5.00 (-43.7%) * Over Last 12-Mos
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/18/2022 BTIG
» Updated 8/16/2023
Mark A. Massaro Downgrade Sell
(Neutral)
5.00
(0.35)
1.42
(8.88)
525.35% Details
1/7/2022 BofA Securities Derik de Bruin Downgrade Underperform
(Neutral)
3.00
(N/A)
3.53
(8.88)
151.56% Details
Like TLIS Ratings? Also take a look at BAX

TLIS Ratings News